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Cerebrovascular reactivity (CVR) is used as an outcome measure of brain health.
Traditionally, lower CVR is associated with ageing, poor fitness and brain-related
conditions (e.g. stroke, dementia). Indeed, CVR is suggested as a biomarker for
disease risk. However, recent findings report conflicting associations between ageing or
fitness and CVR measures. Inconsistent findings may relate to different neuroimaging
modalities used, which include transcranial Doppler (TCD) and blood-oxygen-level-
dependant (BOLD) contrast magnetic resonance imaging (MRI). We assessed the
relationship between CVR metrics derived from two common imaging modalities, TCD
and BOLD MRI, within the same individuals and with expected significant differences
(i.e., younger vs. older) to maximise the expected spread in measures. We conducted
two serial studies using TCD- and MRI-derived measures of CVR (via inspired 5% CO2
in air). Study 1 compared 20 younger (24 ± 7 years) with 15 older (66 ± 7 years)
participants, Study 2 compared 10 younger (22 ± 2 years) with 10 older (72 ± 4 years)
participants. Combining the main measures across studies, no significant correlation
(r = 0.15, p = 0.36) was observed between individual participant TCD- and BOLD-CVR
measures. Further, these measures showed differential effects between age groups;
with TCD-CVR higher in the older compared to younger group (4 ± 1 vs. 3 ± 1
%MCAv/mmHg PETCO2; p < 0.05, Hedges’ g = 0.75), whereas BOLD-CVR showed
no difference (p = 0.104, Hedges’ g = 0.38). In Study 2 additional measures were
obtained to understand the origin of the discrepancy: phase contrast angiography
(PCA) MRI of the middle cerebral artery, showed a significantly lower blood flow (but
not velocity) CVR response in older compared with younger participants (p > 0.05,
Hedges’ g = 1.08). The PCA CVR metrics did not significantly correlate with the BOLD-
or TCD-CVR measures. The differing CVR observations between imaging modalities
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were despite expected, correlated (r = 0.62–0.82), age-related differences in resting
CBF measures across modalities. Taken together, findings across both studies show no
clear relationship between TCD- and BOLD-CVR measures. We hypothesize that CVR
differences between imaging modalities are in part due to the aspects of the vascular
tree that are assessed (TCD:arteries; BOLD:venules/veins). Further work is needed to
understand the between-modality CVR response differences, but caution is needed
when comparing CVR metrics derived from different imaging modalities.
Keywords: cerebrovascular reactivity, transcranial Doppler, magnetic resonance imaging, ageing, brain vascular
health, cerebral blood flow
INTRODUCTION
The methods chosen through which to assess brain health and
individual vascular disease risk (e.g., stroke), as well as the efficacy
of approaches to improve brain health are important areas of
research to improve the healthspan of individuals (i.e., the period
of one’s life that is healthy). One method which is becoming
established for the assessment of brain health and a potential
biomarker for disease risk is cerebrovascular reactivity (CVR)
(e.g., Kleiser and Widder, 1992; Silvestrini et al., 2000; Portegies
et al., 2014; Smeeing et al., 2016; Juttukonda and Donahue,
2019; Sur et al., 2020). CVR is the reactivity of blood vessels
in the brain to an external isometabolic (i.e., no change in
brain metabolism) stimulus. The idea is to assess how cerebral
blood flow (CBF) changes when a stimulus is presented. To
disassociate the vascular response to changes in neuronal activity
between cohorts or time points of interest, the stimulus of
choice is often carbon dioxide (CO2), a potent vasodilator of
the cerebrovasculature (Willie et al., 2014). Furthermore, it is
thought to cause only a small change in the cerebral metabolic
rate of oxygen consumption (CMRO2) (Peng et al., 2017), and
is readily available and easy to administer. Following a period of
resting (baseline) CBF measures, CBF is then assessed whilst the
partial pressure of CO2 in the arteries (PaCO2) is altered either via
increases in the inspired CO2 concentration (i.e., hypercapnia)
to elevate CBF, or from hyperventilation to lower PaCO2
(i.e., hypocapnia) and reduce CBF. The changes in PaCO2 are
quantified via measures of CO2 in the expired breath (i.e., end-
tidal CO2 (PETCO2)). By taking the ratio of the relative change
in CBF to the change in PETCO2, the relative CVR is found. This
CVR measure therefore gives a metric of the regulatory function
of the brain’s vasculature (Fierstra et al., 2013).
There are a range of methods to measure CBF, and hence CVR,
either directly or indirectly. Positron emission tomography (PET)
and single photon emission computer tomography (SPECT)
(Juttukonda and Donahue, 2019) both can provide measures of
CBF, but require the use of radioactive isotopes and therefore
are undesirable to use unless clinically beneficial. Non-ionising
methods of measuring CVR are primarily through the use
of Doppler ultrasound or Magnetic Resonance Imaging (MRI)
(Juttukonda and Donahue, 2019). Transcranial Doppler (TCD)
measures blood velocity within an artery [often the middle
cerebral artery (MCA)] as a proxy for CBF. For the use of
velocity as a proxy for flow to be valid, it assumes that there is
no change in the cross-sectional area of the artery on stimulus
administration, and that this effect is consistent between the
compared cohorts. However, it has recently been shown that
there are likely to be changes in blood vessel diameter with
gas challenge (Verbree et al., 2014; Coverdale et al., 2017), as
well as an increase in blood velocity. Doppler ultrasound of the
extracranial arteries (internal carotid and vertebral arteries) is
being used increasingly commonly to overcome this limitation
as both diameter and velocity can be measured simultaneously
for the calculation of flow (Thomas et al., 2015); however, this
method is not yet as widely used as TCD for CVR due to it being
somewhat more technically demanding to perform. Nevertheless,
despite its velocity-based limitation, TCD is still frequently used
to assess CVR due to its low cost, portability and the fact that any
cohort can be imaged with this technique (i.e., there are no safety
implications unlike MRI).
MRI-based CVR measures have most commonly been
performed by utilising the blood oxygen level dependant (BOLD)
signal due to its high signal-to-noise ratio (SNR) and easy
accessibility to MRI sequences that can measure this signal.
The BOLD signal is increased in the presence of reduced
concentration of deoxyhaemoglobin (Ogawa et al., 1990) and
reflects the complex balance of CBF, CMRO2 and blood volume
that together alter the concentration of deoxyhaemoglobin. Since
the BOLD signal is sensitive to changes in the concentration
of deoxyhaemoglobin, the signal measured is from the venous
side of the vascular tree and is primarily thought to originate
in the venules (Ogawa et al., 1990; Gagnon et al., 2015). The
BOLD signal therefore provides an indirect measure of changes
in CBF in the venules. The BOLD signal is used extensively
to examine brain vascular response to an external stimulus,
including to induced changes in PaCO2 as described above,
with an assumption that such a hypercapnic challenge results
in no change in neuronal activity and therefore CMRO2 (Febo,
2011; Buxton, 2013; Peng et al., 2017). In addition to the BOLD
approach, other MRI techniques are also used to assess CVR.
These include arterial spin labelling (ASL), which measures CBF
in the grey matter tissue (Alsop et al., 2015), and phase contrast
angiography (PCA), which measures blood velocity and flow in
large vessels such as the MCA. However, ASL has poor SNR
relative to BOLD, and PCA has a very poor time resolution
(in the order of a minute per measure). Therefore, BOLD CVR
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measures are the most commonly used MRI method, although
the least direct of the MRI options for measuring the signal
of interest, CBF.
Traditionally, higher CVR is associated with higher aerobic
fitness (Bailey et al., 2013; Barnes et al., 2013), while a lower CVR
is associated with natural ageing (Bakker et al., 2004; Lu et al.,
2011; Gauthier et al., 2013, 2015; Bhogal et al., 2016; Peng et al.,
2018; Miller et al., 2019) and brain-related conditions including
dementia (den Abeelen et al., 2014) and stroke (Markus and
Cullinane, 2001). Therefore, a higher CVR has been perceived
as indexing a healthier brain. However, recent findings challenge
some of these observations and assumptions. For example,
blunted CVR was reported in a group of Masters athletes relative
to sedentary age-matched controls (Thomas et al., 2013), and a
recent study showed a similar negative relationship between CVR
and fitness (Furby et al., 2020). This finding has also been shown
in studies of older adults, where higher cardiorespiratory fitness
was negatively related to CVR (DuBose et al., 2016; Intzandt et al.,
2020). In fact, a number of studies report findings that conflict
with the simplistic age-related CVR relationship as well (Kastrup
et al., 1998; Galvin et al., 2010; Murrell et al., 2013). Thus, while
simplistic relationships between CVR and age and/or fitness are
commonly portrayed, there are a lot of inconsistencies within the
literature around this topic.
A plausible explanation for the discrepancy between the CVR
changes reported in different studies is the imaging modality
used. Indeed, while the reduced CVR with greater fitness has been
reported in studies using MRI, primarily using BOLD contrast
CVR (Thomas et al., 2013; DuBose et al., 2016; Furby et al.,
2020), it is Doppler-based imaging methods that show an increase
in CVR with higher fitness levels (Bailey et al., 2013; Barnes
et al., 2013; Murrell et al., 2013). Whilst the majority of studies
show a decrease in CVR with age, the studies where no change
or an increase has been reported are mostly using Doppler as
the imaging modality (Kastrup et al., 1998; Galvin et al., 2010;
Murrell et al., 2013); notwithstanding the sex-differences with
ageing that Kastrup and colleagues reported in their TCD-based
study (Kastrup et al., 1998) and a PET-based study that showed
no ageing effect on CVR (Ito et al., 2002).
Comparison of CVR findings between studies using either
TCD- or BOLD MRI-derived measures are often made to
help the interpretation of a new result with previous studies
on physiologically relevant cohorts. The assumption in such
comparisons is that all CVR measures are reflecting the
same underlying physiology often without consideration of the
imaging method used. However, direct comparison of TCD
and BOLD MRI techniques for measuring CVR has not been
made. The expected relationship between CVR measures across
TCD and BOLD MRI is not immediately clear due to the
different aspects of the vascular tree they are measuring from
(TCD: arteries; BOLD: venules and veins), and the fact both
are providing indirect measures of CBF, as described above. If
CVR is to be a measure of brain health and a biomarker for
disease prognosis and/or diagnosis (as highlighted above), then
it is vital that we understand the precise relationship between
these different approaches that all collectively refer to CVR. Thus,
establishing if these different methods of determining CVR all
reflect the same underlying brain health status is crucial, since
if they provide different information and outcomes, they should
not all be referred to as the same thing; i.e., the single term CVR.
Here we aim to perform a direct comparison of CVR derived
from TCD and BOLD MRI measures, two common methods
used to assess CVR. Importantly, we do this in the same group of
participants with the same experimental setup and CO2 delivery
method. The same experimental set-up was important as aspects
of experimental set-up can also affect the determined CVR
outcome, such as CO2 stimulus concentration and duration, as
well as where the steady-state time point is taken from Burley
et al. (2020). This work combines two studies. The first study
aimed to compare age and fitness effects on CVR within and
between imaging modalities, recruiting both younger and older
adults that were either fit or unfit. Preliminary results of study
one indicated no relationship between TCD and BOLD MRI CVR
measures which required further investigation. The aim of the
second study was to compare CVR outcomes between imaging
modalities for the two groups that were expected to be the most
different (younger fit vs. sedentary older adults). In study two,
PCA MRI was employed to provide a mid-stage measure of CVR
with the aim of furthering understanding of differences in CVR
calculated with TCD and BOLD MRI. We hypothesised that
CVR derived from TCD and BOLD MRI would not correlate
across age and fitness groups, owing to the different origins of the
signal measured; while measured metrics that were more direct
measures of CBF (i.e., MCA velocity measured by TCD vs. PCA
MRI) would show better agreement. This work will help inform
the comparison and interpretation of existing studies using either
of the imaging modalities, as well as how CVR can be used as a
biomarker in the future.
METHODS
For both studies, ethical approval was obtained from the
Science, Technology, Engineering and Mathematics Ethical
Review Committee, University of Birmingham and conformed to
the Declaration of Helsinki (project code: ERN_14-1423). Prior
to participation, a detailed verbal and written explanation of the
study was provided, and written informed consent was obtained.
STUDY 1
Participants
Thirty-five healthy volunteers in two age groups participated:
20 younger participants, mean age 24 ± 7 years and 15 older
participants, mean age 66 ± 7 years. Participants were excluded
if they had any neurological or psychiatric conditions or if any
abnormalities were revealed from a 12-lead electrocardiogram
(ECG). Participants were not taking any medication (with the
exception of oral contraception in females) and had no history
of cardiovascular, cerebrovascular or respiratory disease.
Groups were further divided into fit and unfit groups, as
determined by performance on a maximum oxygen consumption
(V̇O2max) fitness test (see below for details). The partitioning of
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fitness for each age group was as follows: for younger participants,
a V̇O2max > 45 mL·min−1·kg−1 placed them in the fit group;
for the older participants, a V̇O2max > 25 mL·min−1·kg−1
placed them in the fit group. Remaining participants were placed
in the associated unfit groups. Partitioning values were based
on normative data, which includes the well-established decline
in cardiorespiratory fitness across the lifespan (Heyward, 1998;
Riebe et al., 2018).
Overview
Participants for this study completed five visits in total. The first
visit included general health screening, MRI safety screening,
fitness questionnaires, and an electrocardiogram (if over 50 years
of age, see Supplementary Methods). After inclusion, the second
visit comprised the aerobic fitness test on a treadmill or stationary
bike to determine the maximal oxygen consumption (V̇O2max)
of each participant (see Supplementary Methods). The third
visit was a familiarization of the CBF measures using TCD and
gas challenges (not reported). After satisfactory completion of
familiarisation trials (i.e., no adverse reactions to breathing the
CO2 stimulus were experienced by the participant and adequate
Doppler signals were identified), participants were invited back
for the two full testing sessions (visits four and five), one where
MCAv was measured using TCD and one where BOLD and
ASL signals were measured using MRI to give different direct
and indirect measures of brain blood flow at rest and during
the CO2 gas challenge (i.e., CVR test). The order of these
final two visits was randomised and counter-balanced between
participants, using a computer random number generator, to
avoid order effects. For all visits, participants were asked to avoid
vigorous exercise and alcohol for 24 h, caffeine for 12 h and heavy
meals for 4 h prior to study participation.
Cerebrovascular Reactivity Test
Participants were asked to lie in supine position, relax and breathe
as naturally as possible. The CVR test was performed after a
resting period of at least 20 min. It consisted of a sequential
pattern of 4-min period of breathing room air, 4 min of breathing
a 5% CO2 stimulus, 4 min of room air, 4 min of 7% CO2 stimulus,
4 min of room air as shown in Figure 1A.
To ensure mouth breathing only, participants wore a nose
peg whilst breathing through a mouthpiece connected to a 3-
way valve (2700 series: Hans Ruldolph Inc., United States) and
an inhalation and exhalation tube. The inhalation tube was
connected to one of two open-circuit Douglas bags (containing
5% CO2 or 7% CO2 gas in dry air) or left open to room
air. Within this circuit for the TCD session only, was a
heated pneumotachograph (3813 Series, Hans Rudolph Inc.,
United States); however, due to the non-MRI compatibility of
any available spirometer, ventilation volume and rate was not
recorded during the MRI session. Switching the Douglas bag
valves from ambient room air to the 5 and 7% CO2 mixture was
done by a researcher sitting beside the participant for both TCD
and MRI sessions.
During both visits, fractional changes in inspired and expired
oxygen (O2) and carbon dioxide (CO2) were measured via a
sample line inserted into the mouthpiece and connected to
a fast-responding gas analyser (ML206, ADInstruments Ltd,
New Zealand), with the flow rate at maximum (200 mL·min−1).
O2 and CO2 data were acquired continuously at a sample
rate of 1 kHz via an analogue-to-digital converter (PowerLab,
ADInstruments) interfaced with a computer, displayed in
real time and stored for offline analysis using commercially
available software (LabChart v7.3.5, ADInstruments). Known gas
concentrations were used to calibrate the gas analyser prior to
every testing session.
In addition, for the TCD session only, beat-by-beat blood
pressure (BP) was measured using photoplethysmography via
a finger cuff placed on the middle finger of the left hand
(Portapres, Finapres Medical Systems BV, the Netherlands). A 3-
lead electrocardiogram (ECG) was used in the TCD session to
continuously measure heart rate. During the MRI visit, cardiac
and respiratory cycles were simultaneously recorded using the
vector cardiogram (VCG; Philips Medical Systems, Netherlands)
and respiratory belt, respectively.
MRI Data Acquisition
All MRI data were acquired on a 3-T Philips Achieva MRI
scanner (Philips Medical Systems, Best, Netherlands) using a
whole-body transmit coil and 32 channel head receive coil.
Figure 1A shows the times that the different MRI sequences used
were acquired relative to the gas challenges.
A multi-inversion time flow-sensitive alternating inversion
recovery (FAIR) pulsed ASL sequence with two-dimensional
echo-planar imaging (2D-EPI) readout (Kim, 1995) was used to
acquire quantifiable measures of baseline perfusion and transit
time. Imaging parameters used were: echo time (TE): 9 ms;
repetition time (TR): 8 s; inversion times (TIs): 0.4, 0.6, 0.8, 1.0,
1.2, 1.4, 1.6, 1.8 s voxel size: 3.25 mm × 3.25 mm in plane;
slice thickness: 5 mm; slices: 12. Four volumes of data were
acquired for TIs between 0.4 and 1.4 s whilst 10 volumes of data
acquired for TIs between 1.6 and 1.8 s, due to lower SNR at longer
TIs. A base equilibrium M0 scan was acquired with the same
parameters but without the inversion pulses required for ASL
sequence (further details can be found in Burley, 2018; Burley
et al., in press).
To allow measurement of CVR using MRI, a FAIR
double acquisition background suppression (DABS) sequence
(Mullinger et al., 2013, 2017) was used for simultaneous
acquisition of ASL and BOLD data during the gas challenge
protocol (Figure 1A). Imaging parameters used were: TR = 5.2
s (label-control pair), with background suppression pulses at
TBGS1/TBGS2: 339 ms/899 ms, label delay = 1400 ms, TE = 9 ms
(ASL)/40 ms (BOLD), voxel size: 3.25 mm× 3.25 mm× 5 mm, 12
slices of ASL and BOLD data, FOV: 212 mm × 212 mm, SENSE
factor: 2.3, volumes: 205 (label-control pairs). A whole-head
T1-weighted anatomical (magnetisation prepared rapid gradient
echo; MPRAGE) image with 1 mm3 resolution was also acquired.
TCD Data Acquisition
Blood velocity in the right and left MCA were measured
simultaneously using TCD (Doppler Box, DWL, Compumedics
Ltd, Germany), with a 2-MHz probe placed over each temporal
window on the right and left side of the head. Probes were
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FIGURE 1 | Baseline CBF and cerebrovascular reactivity (CVR) test protocol schematic and accompanying measure timing information for MRI and TCD sessions.
(A) Protocols for Study 1. (B) Protocols for Study 2. Note for TCD data – data were recorded over whole gas challenge but only data during highlighted time windows
was used to calculate CBF and CVR metrics. CO2 onsets: are when the CO2 gas (5 or 7%) were presented relative all the imaging data which were acquired. CBF,
cerebral blood flow; PCA, phase contrast angiography; TCD, transcranial Doppler; MCA, middle cerebral artery; FAIR, flow-sensitive alternating inversion recovery;
ASL, arterial spin labelling; BOLD, blood oxygen level dependant; EPI, echo planar imaging; MPRAGE, magnetisation prepared rapid gradient echo.
prepared with ultrasound gel and held in place with a headset.
Search and identification procedures were done in accordance
with established guidelines (Willie et al., 2011). Data were
acquired from the whole of the gas challenge protocol from which
both resting blood velocity and CVR metrics could be obtained,
including a period of steady state (see Figure 1A).
STUDY 2
Participants
Twenty healthy volunteers in two age groups participated: 10
younger fit participants (22 ± 2 years) and 10 older participants
(72 ± 4 years) self-reporting as “unfit.” Participants were
excluded if they had any neurological or psychiatric conditions.
Participants were not taking any medication (with exception
of oral contraception for females) and had no history of
cardiovascular, cerebrovascular or respiratory disease.
Fitness status for the younger group was determined by
performance on a maximum oxygen consumption (V̇O2max)
fitness test as described in Study 1 (>45 mL min−1 kg−1 placed
them in the fit group). For the older group, the physical activity
status was determined using a questionnaire (New Zealand
Physical Activity and Readiness Questionnaire Short Form).
Overview
Younger participants for this study completed six visits in
total. The first visit included general health screening, MRI
safety screening, fitness questionnaires. After inclusion into the
study, the second visit included the aerobic fitness test on
a treadmill or stationary bike to determine maximal oxygen
consumption (V̇O2max) (see Supplementary Methods). The
third visit was a familiarization of the CBF measures using TCD
and gas challenges (not reported). After satisfactory completion
of familiarisation trials (i.e., no adverse reactions to breathing the
CO2 stimulus were experienced by the participant and adequate
Doppler signals were identified), participants were invited back
for the three full testing sessions. The final three visits involved
collecting CBF and CVR measures, two using TCD and the other
using MRI. The order of these three visits was randomised and
counterbalanced between participants using a computer random
number generator. The two visits using TCD were done to assess
test-retest reliability of TCD measures, with the same researcher
collecting all data. The older participants for this study completed
four visits in total, they did not do the fitness test or the second
TCD visit. As for Study 1, for all visits, participants were asked to
avoid vigorous exercise and alcohol for 24 h, caffeine for 12 h and
heavy meals for 4 h prior to study participation.
Cerebrovascular Reactivity Test
Participants were asked to lie supine, relax and breathe as
naturally as possible. The CVR test was performed after a resting
period of at least 20 min. It consisted of two repeats of a 4-min
period of breathing room air followed by 4 min of breathing a 5%
CO2 stimulus, followed by a final 2 min of room air as shown in
Figure 1B. The equipment used for gas delivery and heart rate
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monitoring was identical to Study 1, with the exception of the gas
analyser for the MRI sessions. For this session, a dedicated CO2
analyser (CD-3A, AEI Technologies, United States) was used,
which was calibrated the same way as the analyser used for TCD
(using the same procedures as Study 1).
MRI Data Acquisition
MRI data were acquired using the same hardware as in Study 1.
Figure 1B shows the times that the different MRI sequences were
acquired relative to the gas challenges.
A multi-inversion time FAIR pulsed ASL sequence with
2D-EPI readout, similar to Study 1, was used to acquire
quantifiable measures of baseline perfusion and transit time.
Imaging parameters used were: echo time (TE): 9.6 ms; repetition
time (TR): 3 s; inversion times (TIs): 0.4, 0.6, 0.8, 1.0, 1.2, 1.4,
1.6, 1.8, 2.0 s voxel size: 3 mm × 3 mm × 5 mm; slices: 12. Four
volumes of data were acquired for TIs between 0.4 and 1.4 s whilst
10 volumes of data acquired for TIs between 1.6 and 2.0 s. As for
Study 1, base equilibrium M0 scan was also acquired. In addition,
a whole head EPI with the same resolution and orientation as the
ASL sequence to aid corregistration was acquired.
Blood flow in each vessel was measured using a VCG-gated 2D
phase contrast angiography (PCA) on a single slice perpendicular
to each targeted vessel of interest. Measures in the right and
left MCA were acquired both during the baseline and gas
periods (see Figure 1B). This allowed these PCA measures to
determine blood velocity and flow during baseline (rest) and
PCA-derived measures of CVR, akin to that acquired from
TCD but using velocity and flow measures. Imaging parameters
were: Cardiac cycle phases = 30, TR = 15 ms; TE = 3 ms,
10◦ flip angle, voxel size = 1.21 mm × 1.21 mm × 6 mm,
Velocity encoding = 150 cm/s (allowing for increases during gas
challenge), SENSE factor 2. The order of the PCA acquisitions
was always right MCA followed by left MCA both during the
baseline and gas challenge periods. During the gas challenge
period the acquisition started 90 s after the 5% CO2 stimulus
was started (see Figure 1B). The nominal time for the PCA
acquisition was nominally 44 s, however, the time taken to
acquire the PCA measures varied depending on how robust their
VCG trace was as the R-peak needed to be detected.
To allow measurement of CVR from BOLD MRI in this
study, a double-echo 2D-EPI sequence was used to acquire
BOLD weighted fMRI data during the gas challenge as shown
in Figure 1B (since the ASL data in Study 1 could not be used
due to insufficient SNR [see analysis]). Imaging parameters were
3 s TR; TE1/TE2 = 20/45 ms, 3 mm3 voxel size, 38 slices, 345
volumes, SENSE factor 2. A whole head T1-weighted anatomical
(MPRAGE) image with 1 mm3 resolution was also acquired.
TCD Data Acquisition
TCD data were acquired using the same hardware and researcher
as in Study 1. Again, data were acquired from the whole of the
gas challenge protocol from which both resting blood velocity
and CVR metrics could be obtained, see Figure 1B. Since 2
repeats of the stimulus were given this allowed two measures of
baseline MCAv and the CVR to be determined without the TCD
probe being moved. For the younger participants they returned
for a second measurement session with the same set-up to test
for repeatability of MCAv measures of resting blood velocity
and CVR metrics.
ANALYSIS
For both TCD and MRI visits in both studies, collected gas
fractions were converted to partial pressure measures using the
barometric pressure of that day ((percentage CO2/100)∗(760-
barometric pressure)).
STUDY 1
The 7% CO2 was not tolerated by 4 of the participants, therefore
CVR analysis was only performed on the 5% CO2 challenge.
MRI
Calculating Resting Perfusion and Transit Times
From ASL Data
Data were preprocessed using conventional methods in FSL1 (see
Burley, 2018; Burley et al., in press for details). Resting cerebral
perfusion (mL·100g−1·min−1) and transit time (seconds)
measures were calculated using the FSL Bayesian Inference
for Arterial Spin Labelling MRI (BASIL)2 toolset (Chappell
et al., 2009). ASL data acquired at multiple TIs were fitted
to the kinetic curve model (Lu et al., 2004) so that perfusion
estimation errors associated with variable transit times across
groups could be avoided.
Perfusion and transit times were assessed in all grey matter
tissue as well as several regions of interest (RoIs) within the
grey matter. RoI masks were defined from the conjunction
of the relevant regions from the Harvard atlas (in FSL) and
the normalised individual participant’s grey matter mask. RoIs
used were: whole of right hemisphere, cingulate gyrus, frontal
lobe, motor lobe, occipital lobe and parietal lobe, as previously
employed (Thomas et al., 2013), and we detail elsewhere (Burley,
2018; Burley et al., in press). Mean cerebral perfusion and transit
times across the participant groups were determined for the
whole of the imaged grey matter and the different RoIs.
Calculating CVR From DABS Data
Pre-processing
The DABS data were separated into the BOLD and ASL data
for subsequent analysis. The BOLD data were physiologically
corrected for cardiac and respiratory effects using RETROICOR
(Glover et al., 2000). All data were then motion corrected using
FLIRT (Jenkinson et al., 2002) in the FMRIB Software Library
(FSL, see text footnote 1). Using in-house Matlab programmes,
separately the ASL data (acquired at TE = 9 ms) and BOLD
data (acquired at TE = 40 ms) were linearly interpolated (Interp
function, Matlab, Mathworks United States) to an effective TR
of 2.6 s. Label-control pairs of ASL data were subtracted (using
1https://fsl.fmrib.ox.ac.uk/fsl/fslwiki
2https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/BASIL
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simple subtraction) to create perfusion weighted (CBF) images.
BOLD-weighted image pairs were averaged to produce mean
BOLD-weighted data. Further pre-processing was carried out
in FSL. BOLD data were normalised to the standard Montreal
Neurological Institute (MNI) template. After inspection of CBF
data it was decided that further analysis could not be performed
due to the inherently low SNR producing spurious variability
during baseline and CVR gas challenges. Therefore, the post-
processing stages outlined below were only carried out on the
BOLD data to give a measure of CVR.
Post-processing
Firstly, the mean BOLD signal for each volume over the
individual-subject grey matter tissue mask (i.e., excluding veins)
was calculated. The vein mask was created by plotting a histogram
of the percentage BOLD signal change to the entire gas challenge
across the grey matter and where this change was greater than
15%, signal was regarded as a vein response and excluded.
PETCO2 readings were downsampled to the sampling rate of
the BOLD data (2.6 s). To account for the delay in the PETCO2
readings relative to the BOLD readings (due to the gas sampling
line length), the mean BOLD signal intensity from the grey
matter only was temporally aligned with the PETCO2 (mm Hg)
trace using an iterative process to maximise the correlation of
the BOLD and PETCO2 trace over the whole timecourse, as
performed previously (Yezhuvath et al., 2009; Thomas et al.,
2013).
A general linear model (GLM) was constructed containing
eight regressors (PETCO2 trace aligned to the BOLD signal, linear
drift and six movement parameters) in SPM83. To allow for
the fact not all participants completed the 7% CO2 stimulus,
the GLM only consisted of the data for the first 11 min of the
DABS acquisition to only include the 5% CO2 challenge and
surrounding baseline periods (see Figure 1A). The beta weight
related to the PETCO2 regressor at each voxel provided a metric of
CVR in units of % BOLD signal change/mmHg PETCO2 change
at each voxel (Thomas et al., 2013). The mean GLM-derived CVR
over all grey matter and different RoIs were calculated as was
done for baseline CBF measures.
Calculating Baseline Blood Velocity and CVR
Using TCD









where Vbase is the baseline (resting) velocity averaged over
60 s of stable resting data and averaged over the left and right
hemisphere MCA. V5%CO2 is the blood velocity during the 5%
CO2 measured from 2.5 min into the stimulus duration and
averaged over 30 s (see Figure 1A), in line with best practice
(Burley et al., 2020), and averaged over the left and right
hemisphere MCA. PETCO2base and PETCO25%CO2 are the mean
PETCO2 (mm Hg) signal from the same time windows as the
3https://www.fil.ion.ucl.ac.uk/spm/
blood velocity measures; for the baseline and 5% CO2 measures,
respectively. The Vbase measure averaged over the right and
left MCA was taken as the baseline velocity measure from the
TCD acquisition.
It is important to note that MCA measures of blood
velocity across hemispheres were averaged wherever possible
as no significant difference (paired t-test) was found between
hemispheres during baseline or gas challenge. However, in
participants where only one MCA could be insonated, then this
single recording was taken for that participant as no difference in
MCAv is expected between hemispheres (Billinger et al., 2017; Lee
et al., 2020). In a post-hoc analysis just the right MCA was used,
with the same analysis performed on this single MCA, as analysis
of Study 2 showed greater repeatability in right hemisphere TCD
measures (see Results).
Statistical Analysis
Change in PETCO2 values from baseline to 5%CO2 were
compared between TCD and MRI visits using a paired t-test to
ensure they were not significantly different. Resting CBF and
CVR measures were compared between age and fitness groups
using 2-way ANOVA. We also separately compared younger fit
and older unfit groups for both MRI and TCD outcomes using
independent t-tests, decided a priori as the two groups with the
potential to show the greatest separation (i.e., both age and fitness
effects). The effect sizes were also calculated for between-group
comparisons using Hedges’ g. Hedges’ g was used to calculate
effect sizes between groups as the number of participants in
each group were not the same. Correlational analyses were
performed to investigate correlation between corresponding
measures obtained with the two different imaging modalities.
STUDY 2
MRI
Calculating Baseline CBF Metrics From ASL and
PCA Data
The analysis process for calculating perfusion and transit
times from the ASL data in this study was identical to that
outlined for Study 1.
PCA data were analysed using Q-Flow software (Philips
Medical Systems). For the right and left MCA, a region of interest
was drawn manually around the vessel lumen on each phase
contrast image, with contour detection used. The mean signal
intensity within each of the MCAs reflects blood velocity in that
vessel (cm/s) for each cardiac phase, and the mean velocity across
the cardiac cycle was computed. The cross-sectional area of each
vessel lumen was multiplied by the mean velocity, to compute
mean blood flow (ml/s) in each vessel. Measures from the right
and left MCA were then averaged together as no significant
difference (paired t-test) was found between hemispheres during
baseline or gas challenge.
Calculating CVR From BOLD Data
The double-echo EPI data were separated into the two echoes
for subsequent analysis. The following analysis for each echo was
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as similar as possible to Study 1. For each echo, the BOLD data
were physiologically corrected for cardiac and respiratory effects
using RETROICOR (Glover et al., 2000). Data were then motion
corrected using FLIRT (Jenkinson et al., 2002) in the FMRIB
Software Library (FSL, see text footnote 1) and normalised to the
standard MNI template.
First, the mean BOLD signal from the second echo for
each volume over the individual-subject grey matter tissue
mask (excluding veins) was calculated. PETCO2 readings were
downsampled to the sampling rate of the BOLD data (3 s). To
account for the delay in the PETCO2 readings relative to the
BOLD readings (due to the sample line length), the PETCO2
readings were temporally aligned to mean BOLD signal intensity
from the grey matter as described in Study 1. For each echo, a
general linear model (GLM) was constructed containing eight
regressors (PETCO2 trace aligned to the BOLD signal, linear drift
and six movement parameters) in SPM8 (see text footnote 3). For
each echo, the mean GLM-derived CVR measures (beta-weights)
over all grey matter and different RoIs were calculated.
Calculating CVR From PCA Data
Blood velocity and flow measures from the left and right
MCA during the 5% CO2 gas challenge were obtained from
the PCA data using the same analysis pipeline as outlined for
the baseline PCA measures in this study. These values were
average over right and left hemispheres. In addition, the mean
PETCO2 in the time windows corresponding to the periods when
the baseline and gas challenge PCA data were acquired was
calculated. Equation 1 was now used to calculate the relative CVR
when using the blood velocity measured by PCA to input as
Vbase and V5%CO2 , and then using the blood flow (which takes
account of changes in vessel diameter) to input as Vbase and
V5 % CO2 .
In addition, the same CVR metrics were determined for the
right MCA only, as the reliability of TCD measures in the right
hemisphere was found to be greater (see section “Results”).
TCD
As for Study 1, and shown in Figure 1B, resting MCAv measures
from the TCD data were taken from a 1-min average of stable
resting data in the initial 5-min baseline. The blood velocity
during the 5% CO2 stimulus was measured from 2.5 min into the
stimulus duration and averaged over 30 s (see Figure 1B). CVR
was then calculated using Equation 1.
The reliability of TCD measures was determined, since the
accuracy of Doppler measures are known to be dependent on the
operator and their experience (Willie et al., 2011; Thomas et al.,
2015). The coefficient of variation (CoV [%]) (Bax et al., 2005)
and the correlation between measures was then determined for
each pair of measures within a visit (within visit reliability) and
also between visits (younger group only, with second TCD visit)
for measure 1 and 2 separately (between visit reliability). These
measures were then averaged within and between participants to
give a mean CoV and correlation of the TCD measures within
and between visits for each group.
Statistical Analysis
Change in PETCO2 values from baseline to 5%CO2 were
compared between TCD and PCA MRI visits using a paired t-test
to ensure they were not significantly different. Group means of
resting CBF and CVR measures were compared between the
younger fit and older unfit groups using independent t-tests
for BOLD, TCD and PCA results. The effect sizes were also
calculated for between-group comparisons using Hedges’ g.
Hedges’ g was used to calculate effect sizes between groups as
the number of participants in each group were not the same.
Correlational analyses were performed to investigate correlation
of corresponding measures obtained across modalities.
Pooling Study 1 and 2
To increase power and establish if trends seen separately in
Studies 1 and 2 would result in overall patterns across all the data
collected. BOLD and TCD CVR measures across the two studies
were pooled. Since fitness status was not characterised in the same
way for Studies 1 and 2 (with Study 1 likely to contain fitter older
people in the unfit group than Study 2 as they had to have a clean
ECG trace), data were only pooled and then grouped according to
age. Over these pooled data, group means of CVR measures were
compared between the younger and older groups using t-tests for
BOLD and TCD results, and Hedges’ g used to calculate effects
sizes for the between-group comparisons. Correlational analyses




All data for BOLD and TCD CVR measures to be calculated were
successfully acquired on 18 younger participants (25 ± 7 years,
7 female) and 12 older participants (69 ± 4 years, 5 female).
Comparison of resting CBF measures between MRI and Doppler
are reported elsewhere (Burley, 2018; Burley et al., in press). In
brief, these showed a main effect of age with significant (p < 0.05)
differences between younger and older groups in transit time
(seconds) [Hedges’ g = 1.70], measured from ASL MRI, and
MCAv (cm·s−1) [Hedges’ g = 0.95], as measured with TCD. The
two imaging metrics also significantly negatively correlated with
one another across the whole group (r =−0.63, p < 0.0001).
There were no significant main effects for fitness in any of the
measures of CVR or within either age group (all p > 0.05). As
shown in Figure 2, there were differences between younger and
older groups for CVR measures, however, these were dependent
on imaging modality. Specifically, while a significantly greater
CVR response was observed in the older than the younger group
for the TCD-CVR measure (p < 0.05, Hedges’ g = 1.13), there was
no significant difference between age groups over the whole grey
matter for the BOLD-CVR measure (p = 0.104, Hedges’ g = 0.11).
Furthermore, no significant differences were seen in any of the
sub regions assessed (see Supplementary Figure 1). Given this
disparity between TCD and BOLD group measures, it is not
surprising that no significant correlation was seen between the
BOLD and TCD CVR measures (Figure 2C; r = 0.23, p > 0.05).
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FIGURE 2 | Study 1: Comparison of CVR measures with TCD (A) and BOLD (B) across younger (blue) and older (orange) groups. Error bars show the standard
deviation across the group. * denotes a significant difference (p < 0.05, t-test) between groups. Panel (C) shows the correlation of CVR measures from BOLD and
TCD data, no significant correlation over the whole cohort (n = 30) is seen. TCD, transcranial Doppler; BOLD, blood oxygen level dependant.
FIGURE 3 | Study 1: Comparison of CVR measures with TCD (A) and BOLD (B) across younger fit (blue) and older unfit (orange) groups. Error bars show the
standard deviation across the group. No significant differences (p > 0.05, t-test) between groups are seen. Panel (C) shows the correlation of CVR measures from
BOLD and TCD data, no significant correlation over the whole cohort (n = 15) is seen.
Extreme group comparisons of the two groups with the
expected most likely difference, younger fit (group size: 9, 28± 8
years, 2 female) and older unfit (group size: 6, 70 ± 5 years, 4
female), revealed a similar pattern in the data; although there
was no significant difference between the CVR measures obtained
from either TCD (Figure 3A, Hedges’ g = 0.63) or BOLD
(Figure 3B, Hedges’ g = 0.03) data. In addition, no significant
relationship between BOLD and TCD CVR measures was seen
across this sub-group of the data (Figure 3C; r = 0.33, p > 0.05).
Study 2
TCD and BOLD data required to calculate CVR measures were
successfully acquired on 10 younger fit participants (22 ± 2
years, 3 female V̇O2max = 52 ± 7 mL·kg−1·min−1) and 8 older
unfit participants (72 ± 4 years, 2 female). Two of the older
participants did not manage to complete the whole MRI visit.
In addition, resting ASL data were successfully acquired on all of
these 18 participants, as well as PCA data both at rest and during
5% CO2, although one PCA data set for an older participant was
missed due to technical problems.
Consistent with findings from Study 1, measures of resting
CBF from TCD MCAv and ASL MRI transit time were
significantly negatively correlated (r = −0.61, p < 0.05)
across the whole sample when considering whole grey matter
and average MCAv across hemispheres (see Supplementary
Figure 2A). There was a complementary relationship between
the whole grey matter transit times and the average MCA
velocity (Supplementary Figure 2B, r = −0.68, p < 0.05)
and flow (Supplementary Figure 2C, r = −0.68, p < 0.05)
measures derived from the PCA MRI data. In addition, a
significant difference (p < 0.05) between younger and older
groups was seen for these baseline CBF measures in all modalities
(Supplementary Figure 3). In the younger group, resting CBF
had significantly higher velocity (measured with both TCD and
PCA) and flow (measured with PCA), which was reflected by
shorter transit times (measured with ASL). However, while the
mean value was lower in the older group, there was no significant
difference in baseline perfusion (measured with ASL) in the grey
matter between groups (Supplementary Figure 3D).
When considering differences in CVR between these targeted
groups of likely difference, no significant differences were seen
between the two groups for the TCD- or BOLD-CVR measures
(Figure 4A; p > 0.05, Hedges’ g = 0.65 and B; p > 0.05, Hedges’
g = 0.70, respectively); although some sub regions interrogated
with the BOLD-CVR measures did show significantly lower
BOLD CVR in the older unfit group (Supplementary Figure 4).
Further, no difference was seen in the CVR derived from
PCA-MCA velocity (Figure 4C p > 0.05, Hedges’ g = 0.67).
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FIGURE 4 | Study 2: Comparison of CVR derived from TCD MCAv (A), BOLD (B), PCA MCA velocity (C) and PCA MCA flow (D) across younger fit (blue) and older
unfit (orange) groups. Error bars show the standard deviation across the group. * denotes a significant difference (p < 0.05, t-test) between groups.
FIGURE 5 | Study 2: Shows the relationship of CVR measures from BOLD
and TCD data. No significant correlation over the whole cohort (n = 18) is
seen.
However, a difference was seen when MCA flow, which accounts
for changes in vessel diameter and blood velocity, was used to
derive CVR (Figure 4D p < 0.05, Hedges’ g = 1.08). Although not
significant, the pattern of difference in CVR derived from both
MCA velocity measures (TCD and PCA-MRI) is that the younger
group have a lower CVR (Figures 4A,C) than the older group,
also in agreement with Study 1 (Figures 2A, 3A). However,
the CVR derived from the BOLD and PCA-MCA flow data
show the younger group have a higher CVR (Figures 4B,D and
Supplementary Figure 4) than the older group. Consistent with
these disparate observations between modalities, there was no
correlation between CVR measures derived from the TCD and
BOLD data (see Figure 5; r = 0.26, p > 0.05). In addition, despite
the similar pattern in MCA velocity-derived CVR measures from
TCD and PCA, these measures of CVR also showed no significant
correlation over the group (Supplementary Figure 5A; r =−0.19,
p > 0.05). Similarly, no relationship between BOLD and PCA
MCA flow was found (Supplementary Figure 5B; r = 0.04,
p > 0.05).
Pooling Study 1 and 2
The data pooled across Studies 1 and 2 allowed investigation
of age effects in a larger group. This resulted in 28 participants
(24± 6 years, 10 female) in the younger group and 20 participants
(57 ± 5 years, 7 female) in the older group. Figure 6 shows the
group differences in CVR determined from TCD (Figure 6A)
and BOLD (Figure 6B). These pooled data revealed significantly
(p < 0.05, Hedges’ g = 0.75) greater CVR in the older than
the younger group as determined from TCD measures. Further,
whilst no significant difference was seen between groups in the
CVR from the BOLD measures over the whole head (p > 0.1,
Hedges’ g = 0.38), there was a trend for a smaller CVR in the
older group than the younger group in the cingulate (p = 0.06;
Hedges’ g = 0.53), and motor (p = 0.05; Hedges’ g = 0.61) regions.
Consistent with these opposing findings, there was no correlation
in CVR determined from TCD and BOLD across the whole group
(Figure 6C; r = 0.15, p > 0.05).
Source of CVR Discrepancy
Given the opposing CVR findings between TCD- and BOLD-
derived measures, we explored potential sources of the
discrepancy that included any potential source due to the
reliability of the TCD measure. It has been suggested BOLD-
CVR should be acquired at a shorter echo time (Liu et al., 2019),
therefore the relationship of CVR between echo 1 and 2 of
these BOLD data were investigated. Study 2 showed the CVR
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FIGURE 6 | Comparison of CVR measures pooled over Study 1 and 2 with TCD (A) and BOLD (B) across younger (blue) and older (orange) groups. Error bars show
the standard deviation across the group. * denotes a significant difference (p < 0.05, t-test) between groups. Panel (C) shows the correlation of CVR measures from
BOLD and TCD data; no significant correlation over the whole cohort (n = 48) is seen.
TABLE 1 | Study 2: Results of test-retest reliability assessment of the TCD measures. Assessment of the coefficient of variation (CoV) and correlation between measures
collected on the right and left MCA during baseline (resting) period and during 5% CO2 gas challenge.
Baseline CO2 gas challenge CVR
Right MCA Left MCA Right MCA Left MCA Right MCA Left MCA Average MCA
Younger: mean within visit measures CoV (%) 3.8 3.6 2.9 2.7 27 22 28
Correlation (r) 0.97 0.92 0.98 0.98 0.66 0.59 0.56
Older: mean within visit measures CoV (%) 4.0 4.2 2.9 1.7 12 14 15
Correlation (r) 0.98 0.99 0.98 0.96 0.68 0.45 0.46
Younger: mean Between visit measures CoV (%) 6.4 9.4 7.8 8.8 33 29 29
Correlation (r) 0.92 0.75 0.89 0.83 0.33 0.34 0.26
The reliability of the calculated CVR value is also presented. For younger people measures are averaged over visits/measures one and two as applicable.
calculated from both BOLD echo times correlated extremely well
(Supplementary Figure 6A; r = 0.94, p < 0.05). Furthermore,
the CVR derived from BOLD echo 1 data and CVR derived
from TCD data were not correlated (Supplementary Figure 6B;
r = 0.20, p > 0.05), reflecting the same finding shown in Figure 5
for BOLD echo 2 data.
The test-retest reliability data of baseline TCD measures
acquired on the participants in Study 2 showed that TCD
results were of a high standard with low coefficients of variation
and a high degree of correlation between measures taken
on the same day and between days (Table 1). There was a
slightly greater variation (lower correlation, higher CoV) between
MCAv measures during the CO2 challenge than during the
resting baseline periods, particularly between visits. Although
the reliability of TCD measures of MCAv during rest or gas
challenge was good, the reliability of the CVR measures within
or between visits was found to be consistently lower (higher
CoV and lower correlation). Across the different measures and
comparisons the reliability appeared to be poorer in the left
MCAv measures. Therefore, it is possible noise in the left
MCAv measures were driving the lack of correlation between
TCD- and BOLD-derived CVR measures. Given these findings,
all of the CVR data were re-calculated using only the right
hemisphere of the brain, that is the right MCA (for TCD and
PCA measures) and the grey matter from the right hemisphere
(for BOLD measures). However, this did not change any of
the findings for the relationship between CVR derived from
different modalities in Study 2 (Supplementary Figure 7). When
considering the combined data from Studies 1 and 2 and
only the right hemisphere, there was no significant correlation
(r = 0.26, p > 0.05) between the TCD- and BOLD-derived CVR
measures observed (Supplementary Figure 8C) nor was there
an agreement between the TCD and BOLD CVR measures for
younger and older groups (Supplementary Figures 8A,B).
DISCUSSION
CVR metrics derived from both TCD and BOLD-MRI measures
are reported to be a biomarker of brain health (e.g., Kleiser
and Widder, 1992; Sur et al., 2020), and even shown to have
prognostic value for stroke risk (Silvestrini et al., 2000; Portegies
et al., 2014; Smeeing et al., 2016). Given this, one might assume
that between-group differences across modalities would be the
same. However, as highlighted in the introduction, there are
many examples in the literature of within and between imaging
modality inconsistencies and contradictions for this brain health
metric, which may originate from what is measured by the
different imaging approaches. Here, we sought to quantify
expected age and fitness differences in the CVR outcome measure
between these two commonly used imaging modality approaches.
We also assessed other MRI metrics of CBF in order to compare
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how more direct measures of CBF align with TCD-derived CVR,
and resting measures between our groups.
Overall, we found complementary relationships between
baseline CBF measures across our cohort for all modalities (TCD
MCAv, PCA MCA velocity and flow, and perfusion transit time)
(Supplementary Figures 2, 3; also see Burley, 2018; Burley et al.,
in press) and a significant difference between younger and older
groups, with the older group showing lower blood velocity and
flow in arteries, and longer time for blood to reach the capillaries.
These clear group differences in baseline measures are in line
with previous reports (TCD: Ainslie et al., 2008; Bailey et al.,
2013; MRI: Liu et al., 2012). However, the relationship between
the CVR metrics derived from the two imaging modalities was
less clear. Most importantly, we observed no within-participant
correlation between the CVR metrics calculated from TCD and
BOLD MRI over whole datasets (Figures 2C, 5, 6C). When
considering differences between groups, we found that CVR was
significantly lower in the younger group than the older group
when derived from the TCD MCAv data (Figures 2A, 4A, 6A);
whereas a trend in the opposite direction was seen with BOLD
MRI, with higher CVR for the younger group than the older
group (Figures 2B, 4B, 6B). It is worth noting that the direction
of this BOLD-CVR trend is in better agreement with most of the
age-related CVR changes reported in the literature (Bakker et al.,
2004; Lu et al., 2011; Bailey et al., 2013; Oudegeest-Sander et al.,
2014; Gauthier et al., 2015; Bhogal et al., 2016; Peng et al., 2018;
Miller et al., 2019), which includes both MRI and TCD-derived
approaches. Our findings may explain the discrepancies that are
currently being reported in the literature when comparing fit
and unfit groups or younger and older cohorts (as illustrated in
the Introduction), where either BOLD MRI or TCD are being
used to determine CVR. The following discussion will examine,
based on our findings, the possible sources of the differences in
CVR results across imaging modalities, and suggest what could
be done to ensure that CVR is a reliable metric of brain health
and biomarker in the future.
Sources of CVR Differences Across
Imaging Modalities
Measurement Inaccuracy and Analysis Methods
Perhaps the easiest explanation for the lack of CVR relationships
would purely be insufficient data quality in either one of
the imaging modalities to allow comparison across modalities.
However, if this were the case we would expect no relationship
to be seen in the baseline measures across imaging modalities,
which is not the case. Indeed, a strong relationship between
CBF measures from the different modalities of TCD, PCA MRI
and ASL MRI was observed (Burley, 2018; Burley et al., in
press; Supplementary Figures 2, 3) and the between-group
differences obtained with different modalities agreed with one
another in these resting CBF measures, which was not seen in
the CVR measures.
The acquisition of the TCD measures is the most challenging
of the measures taken in this study, as it requires the researcher
to find the MCA in the same way each time (Willie et al.,
2011); potentially making the reproducibility of these measures
the lowest. Therefore, the test re-test reliability of the TCD data
was assessed in Study 2 to determine if the CVR discrepancies
observed in the conventional TCD and MRI measures could all
be explained by poor repeatability. When comparing TCD data
to MRI data the most relevant measure is the between visits
measure, which still shows a low CoV and strong correlation
between MCAv measures taken in different visits (Table 1).
Furthermore, there is not a clear change in the reliability of this
measure when the participant is breathing the gas compared
with the baseline measures. Whilst a strong correlation was seen
between the MCAv measures done on different days with TCD;
the relationship between TCD CVR measures from different days
was weaker (Table 1). However, the correlation between TCD
CVR measures (average r = 0.43) taken was still much greater
than the relationship of the TCD CVR measures to the CVR
measures derived from PCA MRI (Supplementary Figure 5A,
r = −0.19), which would have been expected to provide similar
CVR measures. To fully be able to interpret these results it
would be necessary to also assess test re-test reliability in the
MRI CVR measures to try and disentangle if it is participant
physiology (Shoemaker et al., 2020) or measurement technique
that is driving this variability and is contributing to the lack
of correlation between modalities. Nevertheless, the variability
that we observed with the TCD-CVR is consistent with other
studies that have reported CoV for this measure (Shoemaker
et al., 2020) and/or examined its variability (Burley et al., 2020).
Finally, the PCA MRI-derived flow measure of CVR in the MCA,
which is not affected by the operator to the same extent as TCD
acquisition, also did not correlate with the BOLD CVR metrics
(Supplementary Figure 5B).
In addition, if random noise is the reason that a correlation is
not seen between TCD and MRI CVR measures, then a larger
cohort than that used in these studies would provide further
insight into the relationship between measures. However, if this
is the case then the utility of CVR as a biomarker (see later
discussion) would become questionable, as when we combined
our data across both studies we had measures on 48 people
included (Figure 6C). Whilst a limitation of this work is the
number of people who took part in Study 2, the additional
information acquired on these participants was designed to
inform the overall finding across all data. Indeed, this combined
cohort from Studies 1 and 2 confirmed our initial observations
that there was not a clear correlation between CVR metrics
derived from TCD and BOLD measures.
An alternative explanation for the lack of correlation between
CVR metrics is how CVR is calculated for different imaging
modalities. It is known that the segment of data that is used to
calculate CVR can affect the CVR outcome measure and therefore
this might, at least in part, explain the lack of correlation (Burley
et al., 2020). For BOLD data, the typical analysis strategy is to
calculate CVR from the entire BOLD and PETCO2 timecourse,
via a GLM (Liu et al., 2019), which was employed as the
primary method in the current work. By doing this the analysis
includes the transition periods as the participant goes on and
off the gas stimulus, and thus the integrated ventilatory response
that influences this open circuit-type of CVR test (Battisti-
Charbonney et al., 2011; Duffin et al., 2017) and the time course
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of this effect (Burley et al., 2020), which could affect the calculated
CVR. Whereas, CVR determined from TCD data is calculated
through a relative change of average blood velocity during the
gas challenge, once a steady state is reached, from the average
baseline blood velocity (Fierstra et al., 2013), thus not including
the transition periods.
Given the differences in how the CVR metric is typically
derived for different imaging modalities, we investigated if these
differences may be driving the discrepancy in the CVR outcome
measure across modalities. Using the data obtained in Study
1 we also checked to see if the analysis strategy explained the
differences between CVR metrics obtained in different imaging
modalities. We found that if the BOLD data signal was taken from
the whole of the grey matter mask and then CVR was calculated
using the same 30-s time windows used in the TCD analysis,
there was no clear effect between groups on the CVR measure
calculated. Similarly, if TCD data were used as a continuous time
course (including the transition periods) and linearly regressed
against the PETCO2 measures, akin to a GLM, then again no
clear effect on the CVR measures was seen. Thus, general patterns
between groups remained the same when CVR was calculated in
different ways from the BOLD data (see Figure 5.4, Burley, 2018),
and, if anything, making the difference seen more pronounced
and therefore a bigger discrepancy with CVR derived from TCD
data. As such, the analysis methodology is unlikely to be the
source of differences seen between our CVR measures derived
from TCD and BOLD MRI.
Biophysical Origins
The simplest explanation in terms of the vascular response that
might be causing the differences in CVR is the fact that both
TCD and BOLD MRI are providing indirect measures of CBF,
which is the parameter of interest for characterising CVR. When
considering CVR calculated from TCD, the changes in vessel
diameter with CO2-induced vasodilation are not accounted for
Ainslie and Hoiland (2014); Verbree et al. (2014); Coverdale et al.
(2017). Thus, velocity increases may be greater, but diameter
increases less in the older group with the gas challenge; causing
opposing CVR changes between groups across measures. It is
hard to predict the dominance of these two effects on the
BOLD signal, which will reflect the accumulation of velocity
and diameter changes over the cerebrovascular tree given BOLD
reflects overall concentration of deoxyhaemoglobin within the
blood. The general hypothesis that there are changes in velocity
and vessel diameter that both alter with age is supported by
the work of Coverdale and colleagues, who found that the
percentage change of the MCA cross sectional area was smaller
for older people than younger people when given a gas challenge
(Coverdale et al., 2017). Indeed, our PCA MRI data also supports
this hypothesis as it showed opposite effects between the younger
and older groups when the MCA blood velocity (Figure 4C)
or the MCA blood flow (Figure 4D) were used to determine
CVR. However, our PCA measures of CVR did not significantly
correlate with the TCD- or BOLD MRI-derived CVR measures
over the whole group (Supplementary Figure 5). To verify this
putative explanation for the differences between groups, data are
required that accurately maps the blood vessel diameter changes
with gas challenge compared with rest in different cohorts,
building on the work of Verbree and colleagues (Verbree et al.,
2014) and relating this to CVR measures obtained in the same
session. It should also be noted with regards to cross modality
comparison, that velocities measured with PCA are typically
found to be 30–40% lower than those measured with TCD
(Juttukonda and Donahue, 2019), however, as this is thought to
be a systematic offset it is unlikely to explain our data. We suggest
that whilst vessel diameter changes are likely to be some of the
source of discrepancy, caution should be taken that this can fully
explain the differences given our PCA MRI results.
It is known that the BOLD signal is affected by many factors
other than changes in CBF. For example, changes in blood
volume alone can cause changes in the BOLD signal, where an
increased blood volume, with no changes in CBF or CMRO2,
results in a decrease in the BOLD signal (Buxton et al., 1998). As
discussed above, if vessel diameter changes with CO2 challenges
are different between age groups, this could be contributing
to the overall CVR metrics calculated from the BOLD signal.
This is because it is well known that increases in cerebral blood
volume driven by increases in vessel diameter reduce the BOLD
signal (if there are no changes in CMRO2 or CBF), whereas,
increases in CBF will increase the BOLD signal (Buxton et al.,
1998). Therefore these two changes will have opposing effects
on CVR determined by BOLD. Furthermore, baseline levels of
haematocrit will also affect the amplitude of the BOLD signal
change with the CO2 stimulus (Xu et al., 2018). As haemoglobin
decreases with age (Mahlknecht and Kaiser, 2010), a smaller CVR
response with increased age could be explained by these altered
baseline levels of haemoglobin. Any change in haematocrit is not
going to be reflected in the TCD or PCA-MRI data, which may
explain why the CVR metrics calculated from both the TCD and
PCA-MRI do not correlate with the BOLD-MRI CVR metrics.
An alternative, and most likely, explanation is that CVR
metrics made with BOLD MRI and TCD are measuring different
parts of the vascular tree. TCD is measuring blood velocity
changes in the arteries, whilst BOLD MRI is primarily measuring
the change in concentration of deoxy-haemoglobin in the venules
and veins. Simplistically, one could assume that this difference
may not matter as the blood going into the brain through the
arteries must come out through the veins, and therefore changes
in CBF must be reflected in both the arteries and the veins.
However, the changes in vessel diameters due to CO2 are not
uniform throughout the vascular tree (Piechnik et al., 2008).
Moreover, if these changes in vasodilation across the vascular
tree, for example driven by changes in endothelial function, are
also dependent on the tested cohort (i.e., age or pathology) then
CVR metrics calculated in different parts of the vascular tree
will not correlate. Several studies have provided some evidence
to support this explanation. For example, different CVR in large
veins compared with large arteries has been shown using TCD
(Valdueza et al., 1999), although these measures are clearly
limited by unknown changes in vessel diameter. Using PCA-
MRI, Geurts and colleagues have recently shown that there
is a difference in CVR measured in arterioles compared with
large arteries (Geurts et al., 2018). Indeed, other Doppler studies
have shown that not even all arteries behave the same with
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regards to CVR (Sato et al., 2012; Willie et al., 2012; Carr et al.,
2020). Therefore these studies suggest that there is a vessel type
dependence for CVR measures (Schlader et al., 2013).
Taken together, the previous studies (Valdueza et al., 1999;
Sato et al., 2012; Willie et al., 2012; Geurts et al., 2018; Carr et al.,
2020) and our findings may indicate there are differences in the
vascular reactivity of the arter(iole)s compared with the venules
and veins, which change with age and perhaps also pathology.
Different imaging techniques are sensitive to different parts of
this vasculature tree. Therefore, across modality comparisons
of CVR results should be performed with extreme caution.
Unfortunately this has not been done within the literature to date,
likely due to an expectation that these measures were reporting
the same effect. However, with the work presented herein and the
work of others there is an emerging picture highlighting that a
combined imaging approach may allow us to differentiate more
precisely which part of the vascular tree is compromised in a
particular cohort, and thus providing a greater understanding
of the pathology and treatment paths in the future. If proven
through future work, this will be vital for the use of CVR as
an accurate biomarker as is being proposed (e.g., Smeeing et al.,
2016; Juttukonda and Donahue, 2019; Sur et al., 2020).
Future work to help further understand the results presented
here should include simultaneous TCD and MRI measures.
Whilst considerable effort was made in the current work to
make the MRI and TCD session measurements as similar as
possible (e.g., standardised exercise and diet, and matched time
of day), there are still considerable differences in CVR measures
taken on different days that are believed to have biophysiological
origins (Shoemaker et al., 2020). Indeed, we have previously
shown the TCD-based CVR measures can have considerable
variation even when repeated on the same day within the same
session (Burley et al., 2020). Therefore, we suggest that to
eliminate the source of CVR discrepancy being due to different
biophysiological responses on different days or times it would be
necessary to make simultaneous recordings with the MRI and
TCD approaches. In addition, future investigation to prove the
hypothesis that different aspects of the vascular tree are reacting
in different ways could include 4D flow PCA measures (Miller
et al., 2019) at ultra-high field (Kang et al., 2016) to potentially
allow the investigation of blood velocity and flow changes in
arteries, arterioles, venules and veins simultaneously during
gas challenges. However, considerable work will be required to
optimise data acquisition to make such measures feasible as the
baseline velocities across the vascular tree and changes in these
with gas challenge would mean using a single velocity encoding
value would limit the sensitivity of the technique to some of
the vascular tree.
In conclusion, we have shown that despite clear relationships
between baseline CBF measures from TCD and MRI and
significant group differences (younger compared with
older participants), there were no direct, within participant,
correlations between CVR metrics calculated from TCD and
MRI (BOLD and PCA) measures during a 5%CO2 challenge.
Consistent with this lack of correlation, we showed opposing
group effects between younger and older participants for CVR
outcomes from TCD compared with BOLD MRI (i.e., CVR
higher in older than younger for TCD, but vice versa for BOLD
MRI). These findings challenge the validity of comparing
CVR metrics across studies using different imaging modalities,
but rather highlight that extreme caution should be taken if
comparing CVR measures from a different imaging modality
in another published study. However, since TCD and BOLD
MRI target different parts of the vascular tree, they may be used
together in the same cohorts to better understand the part(s) of
the vascular tree that are compromised in a particular disease,
providing a more detailed biomarker than either modality on its
own. Nevertheless, further work is needed to better understand
the source of imaging metric discrepancies in order that they
may be better utilised for complementary, targeted, multimodal
imaging to determine brain health.
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